Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0HCDAC
ADC Name
ATRC-301
Synonyms
ATRC301; ATRC 301
   Click to Show/Hide
Organization
Atreca, Inc.
Drug Status
Investigative
Indication
In total 5 Indication(s)
Breast cancer
Clinical candidate
.
Colorectal cancer
Clinical candidate
.
Extremity melanoma
Clinical candidate
.
Non-small cell lung cancer
Clinical candidate
.
Ovarian cancer
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Ephrin type-A receptor 2 (EPHA2)
  Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed